P
Petra Marusic
Researcher at Peter MacCallum Cancer Centre
Publications - 2
Citations - 914
Petra Marusic is an academic researcher from Peter MacCallum Cancer Centre. The author has contributed to research in topics: Prostate cancer & Radiation therapy. The author has an hindex of 1, co-authored 2 publications receiving 357 citations.
Papers
More filters
Journal ArticleDOI
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study
Michael S Hofman,Michael S Hofman,Nathan Lawrentschuk,Roslyn J. Francis,Roslyn J. Francis,Colin Tang,Ian Vela,Paul Thomas,Paul Thomas,Natalie Rutherford,Jarad Martin,Mark Frydenberg,Ramdave Shakher,Lih-Ming Wong,Kim Taubman,Sze Ting Lee,Edward Hsiao,Paul Roach,Michelle K. Nottage,Ian Kirkwood,Ian Kirkwood,Dickon Hayne,Emma Link,Emma Link,Petra Marusic,Anetta Matera,Alan Herschtal,Amir Iravani,Amir Iravani,Rodney J. Hicks,Rodney J. Hicks,Scott Williams,Scott Williams,Declan G. Murphy,Declan G. Murphy +34 more
TL;DR: PSMA PET-CT is a suitable replacement for conventional imaging, providing superior accuracy, to the combined findings of CT and bone scanning, andSubgroup analyses showed the superiority of PSMAPET-CT (area under the curve of the receiver operating characteristic curve 91% vs 59% [32% absolute difference; 28-35] for patients with pelvic nodal metastases, and 95% vs 74% [22%absolute difference; 18-26] for Patients with distant metastases).
Journal ArticleDOI
The “ProPSMA Study” clinical trial protocol: A prospective randomized multi-center study of the impact of Ga-68 PSMA PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy.
Michael S Hofman,Declan G. Murphy,Scott Williams,Tatenda Nzenza,Alan Herschtal,Anetta Matera,Petra Marusic,Richard De Abreu Lourenco,Dale L. Bailey,Amir Iravani,Rodney J. Hicks,Roslyn J. Francis,Nathan Lawrentschuk +12 more
TL;DR: A 300 patient phase III multi-centre randomized study of patients with untreated high-risk prostate cancer to compare the accuracy of PSMA-PET/CT to conventional imaging for detecting nodal or distant metastatic disease and the improved diagnostic accuracy will result in significant management impact.